# Cardiomyopathy and Myosin Studies

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/cardiomyopathy-and-myosin-studies/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the diagnosis, management, genetic basis, and clinical outcomes of hypertrophic cardiomyopathy. It explores topics such as cardiomyopathies, myosin mutations, left ventricular non-compaction, sudden death risk, cardiac imaging, titin mutations, dilated cardiomyopathy, and cardiac fibrosis. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t10882 |
| Works | 221 |

## Topic papers all

Showing 15 of 221.

- [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy](https://scholariq.org/papers/2014-esc-guidelines-on-diagnosis-and-management-of-hypertrophic-cardiomyopathy/)
- [Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases](https://scholariq.org/papers/current-state-of-knowledge-on-aetiology-diagnosis-management-and-therapy-of/)
- [Contemporary Definitions and Classification of the Cardiomyopathies](https://scholariq.org/papers/contemporary-definitions-and-classification-of-the-cardiomyopathies/)
- [Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography](https://scholariq.org/papers/recommendations-for-the-evaluation-of-left-ventricular-diastolic-function-by/)
- [Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases](https://scholariq.org/papers/classification-of-the-cardiomyopathies-a-position-statement-from-the-european/)
- [2023 ESC Guidelines for the management of cardiomyopathies](https://scholariq.org/papers/2023-esc-guidelines-for-the-management-of-cardiomyopathies/)
- [2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy](https://scholariq.org/papers/2011-accf-aha-guideline-for-the-diagnosis-and-treatment-of-hypertrophic-2/)
- [Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias](https://scholariq.org/papers/positional-cloning-of-a-novel-potassium-channel-gene-kvlqt1-mutations-cause/)
- [Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed Modification of the Task Force Criteria](https://scholariq.org/papers/diagnosis-of-arrhythmogenic-right-ventricular-cardiomyopathy-dysplasia-proposed/)
- [Diastolic Heart Failure — Abnormalities in Active Relaxation and Passive Stiffness of the Left Ventricle](https://scholariq.org/papers/diastolic-heart-failure-abnormalities-in-active-relaxation-and-passive-stiffness/)
- [Truncations of Titin Causing Dilated Cardiomyopathy](https://scholariq.org/papers/truncations-of-titin-causing-dilated-cardiomyopathy/)
- [Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions](https://scholariq.org/papers/factors-influencing-infarct-size-following-experimental-coronary-artery/)
- [Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management](https://scholariq.org/papers/statin-associated-muscle-symptoms-impact-on-statin-therapy-european/)
- [Hypertrophic Cardiomyopathy](https://scholariq.org/papers/hypertrophic-cardiomyopathy/)
- [2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy](https://scholariq.org/papers/2011-accf-aha-guideline-for-the-diagnosis-and-treatment-of-hypertrophic/)

## Topic primary papers

Showing 15 of 99.

- [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy](https://scholariq.org/papers/2014-esc-guidelines-on-diagnosis-and-management-of-hypertrophic-cardiomyopathy/)
- [Contemporary Definitions and Classification of the Cardiomyopathies](https://scholariq.org/papers/contemporary-definitions-and-classification-of-the-cardiomyopathies/)
- [Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases](https://scholariq.org/papers/classification-of-the-cardiomyopathies-a-position-statement-from-the-european/)
- [2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy](https://scholariq.org/papers/2011-accf-aha-guideline-for-the-diagnosis-and-treatment-of-hypertrophic-2/)
- [Truncations of Titin Causing Dilated Cardiomyopathy](https://scholariq.org/papers/truncations-of-titin-causing-dilated-cardiomyopathy/)
- [Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions](https://scholariq.org/papers/factors-influencing-infarct-size-following-experimental-coronary-artery/)
- [Hypertrophic Cardiomyopathy](https://scholariq.org/papers/hypertrophic-cardiomyopathy/)
- [2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy](https://scholariq.org/papers/2011-accf-aha-guideline-for-the-diagnosis-and-treatment-of-hypertrophic/)
- [Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/mavacamten-for-treatment-of-symptomatic-obstructive-hypertrophic-cardiomyopathy/)
- [Left Ventricular Non-Compaction](https://scholariq.org/papers/left-ventricular-non-compaction/)
- [2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary](https://scholariq.org/papers/2020-aha-acc-guideline-for-the-diagnosis-and-treatment-of-patients-with/)
- [Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association](https://scholariq.org/papers/current-diagnostic-and-treatment-strategies-for-specific-dilated/)
- [Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy](https://scholariq.org/papers/genotype-and-lifetime-burden-of-disease-in-hypertrophic-cardiomyopathy/)
- [2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary](https://scholariq.org/papers/2011-accf-aha-guideline-for-the-diagnosis-and-treatment-of-hypertrophic-3/)
- [Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic Cardiomyopathy](https://scholariq.org/papers/long-term-effects-of-surgical-septal-myectomy-on-survival-in-patients-with/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.